All Episodes
|
170
|
Dr. Robert Hariri

Podcast 170: Advancing Medicine With Placenta-Derived Cells with Dr. Robert Hariri

Aug 20, 2024

Episode Summary

Join us as we delve into the groundbreaking world of cellular therapies with Dr. Robert Hariri, CEO of Celularity. In this episode, Dr. Hariri takes us on a journey through the cutting-edge innovations that are reshaping the future of medicine. Discover how harnessing the power of the body’s own cells is not just a promise for the future, but a reality today—transforming hope into tangible results across a wide spectrum of diseases. Don’t miss this insightful conversation on the therapies that are revolutionizing healthcare.

Episode Notes

Join us as we delve into the groundbreaking world of cellular therapies with Dr. Robert Hariri, CEO of Celularity.

In this episode, Dr. Hariri takes us on a journey through the cutting-edge innovations that are reshaping the future of medicine.

Discover how harnessing the power of the body’s own cells is not just a promise for the future, but a reality today—transforming hope into tangible results across a wide spectrum of diseases. Don’t miss this insightful conversation on the therapies that are revolutionizing healthcare.

🎙ABOUT DR. ROBERT HARIRI:

Dr. Bob Hariri is a pioneering surgeon, biomedical scientist, and serial entrepreneur with expertise in biomedicine and aerospace. He is the founder, chairperson, and CEO of Celularity, Inc., a leader in human cellular therapeutics, and previously founded Anthrogenesis Corporation, which was acquired by Celgene, where he served as CEO of Celgene Cellular Therapeutics.

He also co-founded Human Longevity, Inc. Dr. Hariri is renowned for pioneering the use of stem cells in treating life-threatening diseases, including the discovery of pluripotent stem cells from the human placenta. His innovations have led to over 170 patents and numerous accolades, including the Pontifical Medal for Innovation and the Thomas Alva Edison Award.

He is an Adjunct Professor of Neurosurgery at Weill Cornell Medical College and serves on various prestigious boards, including the Liberty Science Center and the X PRIZE Foundation. Beyond his medical and scientific contributions, Dr. Hariri is an accomplished jet-rated pilot and film producer.

🎙 ABOUT JOHN MARCHICA, HOST OF HEALTH CARE ROUNDS:

John Marchica is a veteran health care strategist and CEO of Darwin Research Group, a strategic consulting and market intelligence firm focused on hospitals, health systems, physician groups, and the evolving health care ecosystem. John has a degree in economics from Knox College, an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 215: Real Health Care Happens Between Doctor Visits w/ Wei-Li Shao, President, Omada Health
Podcast 214: Mailbag: Debunking Vaccines Myths
Podcast 213: Health Care's Affordability Crisis Is Getting Worse w/ Larry Levitt, CEO-Elect & EVP, KFF
Podcast 212: Are We Measuring Health Care Quality All Wrong? w/ Dr. Rachel Werner, Professor of Medicine, UPenn
Podcast 211: The State of Value-Based Health Care w/ John Marchica, Darwin Research Group
Podcast 210: Why Health Care Reform Keeps Falling Short w/ Dr. Elliott Fisher, Dartmouth Institute
Podcast 209: Inside the Rural Health Transformation Program w/ Dr. Tim Ferris, InterSystems
Podcast 208: The Affordability Crisis Behind Value-Based Care w/ Dr. Michael Chernew, Harvard

Recommended Content

Browse Library
INsights
August 17, 2026

Darwin's Our Take 8.17.26: Trump tries again to revise federal childhood vaccination recommendations

Read More
INsights
August 10, 2026

Darwin's Our Take 8.10.26: Summa Health names new CEO to lead next phase of HATCo's health assurance vision

Read More
INsights
August 3, 2026

Darwin's Our Take 8.3.26: Loss of ‘enhanced’ ACA subsidies hits IDNs harder than expected

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.